title: Rationalizing use of fluoroquinolones and pyrazinamide in the battle against multidrug-resistant tuberculosis.
authors.forename: Kwok-Chiu
authors.initials: KC
authors.lastname: Chang
authors.forename: Keertan
authors.initials: K
authors.lastname: Dheda
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000995:Antitubercular Agents / Q000008:administration & dosage*; D001372:Aza Compounds / Q000008:administration & dosage*; D005260:Female; D024841:Fluoroquinolones; D000077266:Moxifloxacin; D015242:Ofloxacin / Q000627:therapeutic use*; D011718:Pyrazinamide / Q000008:administration & dosage*; D011804:Quinolines / Q000008:administration & dosage*; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D011718:Pyrazinamide; D015242:Ofloxacin; D000077266:Moxifloxacin